Citi Downgrades Puma Biotechnology (PBYI) to Neutral
Tweet
Share
E-mail
Get Alerts PBYI Hot Sheet
Price: $8.83 --0%
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Rating Summary:
5 Buy, 6 Hold, 4 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 7 | Down: 12 | New: 19
Join SI Premium – FREE
Citi analyst Yigal Nochomovitz downgraded Puma Biotechnology (NASDAQ: PBYI) from Buy to Neutral with a price target of $24.00.
For an analyst ratings summary and ratings history on Puma Biotechnology click here. For more ratings news on Puma Biotechnology click here.
Shares of Puma Biotechnology closed at $19.50 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Deutsche Bank Downgrades Workday (WDAY) to Hold
- ATB Capital Markets Downgrades The Westaim Corp. (WED:CN) (WEDXF) to Speculative Buy (2)
- Deutsche Bank Downgrades Netskope (NTSK) to Hold on Valuation
Create E-mail Alert Related Categories
DowngradesRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
